The course of severe foot infection in patients with diabetes
- PMID: 1636138
The course of severe foot infection in patients with diabetes
Abstract
Infection of the foot is a limb threatening condition for patients with diabetes mellitus. Identification of patients with diabetes and severe infection of the foot most likely to benefit from early revascularization or major amputation would improve the results of a treatment policy to prevent limb loss and avoid futile delays in amputation. During a nine year period, 79 diabetic patients underwent emergency procedures for severe infection of the foot during the initial hospitalization period. None of the patients underwent arterial reconstruction. Eventually, 21 of the patients required a major amputation, eight during the initial hospitalization and 13 on a subsequent admission. Stepwise discriminant analysis of clinical independent variables revealed that the patients most likely to require a major amputation during the initial hospitalization were those with an absent dorsalis pedis pulse and a polymicrobial infection (p = 0.018). The overall amputation rate (immediate or subsequent amputation) was higher for patients of either sex with nonpalpable pedal pulses when compared with those with at least one palpable pulse (p less than 0.05). Males who were not dependent on insulin had the highest risk of overall limb loss (p = 0.01). Patients undergoing delayed amputation required a significantly higher number (p = 0.01) of readmissions to the hospital for recurrent infection of the foot than those who did not undergo amputation. Data in the current study suggest that early major amputation in a subset of patients would prevent delay in the rehabilitation process of the amputee, decrease long term morbidity and reduce health care cost. An aggressive policy of early revascularization in patients with a pulse deficit may reduce the amputation rate in those with diabetes with severe infection of the foot.
Similar articles
-
Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status.J Vasc Surg. 1999 Sep;30(3):509-17. doi: 10.1016/s0741-5214(99)70078-9. J Vasc Surg. 1999. PMID: 10477644
-
Competing Risk Analysis of the Impact of Pedal Arch Status and Angiosome-Targeted Revascularization in Chronic Limb-Threatening Ischemia.Ann Vasc Surg. 2020 Oct;68:384-390. doi: 10.1016/j.avsg.2020.03.042. Epub 2020 Apr 9. Ann Vasc Surg. 2020. PMID: 32278873
-
Pedal arterial calcification score is associated with the risk of major amputation in chronic limb-threatening ischemia.J Vasc Surg. 2022 Jan;75(1):270-278.e3. doi: 10.1016/j.jvs.2021.07.235. Epub 2021 Sep 3. J Vasc Surg. 2022. PMID: 34481900
-
Vascular evaluation and arterial reconstruction of the diabetic foot.Clin Podiatr Med Surg. 2003 Oct;20(4):689-708. doi: 10.1016/S0891-8422(03)00088-0. Clin Podiatr Med Surg. 2003. PMID: 14636033 Review.
-
Reducing the incidence of foot ulceration and amputation in diabetes.Curr Diab Rep. 2004 Dec;4(6):413-8. doi: 10.1007/s11892-004-0049-x. Curr Diab Rep. 2004. PMID: 15539004 Review.
Cited by
-
Proinsulin Shares a Motif with Interleukin-1α (IL-1α) and Induces Inflammatory Cytokine via Interleukin-1 Receptor 1.J Biol Chem. 2016 Jul 8;291(28):14620-7. doi: 10.1074/jbc.M116.731026. Epub 2016 May 16. J Biol Chem. 2016. PMID: 27226621 Free PMC article.
-
Costs of deep foot infections in patients with diabetes mellitus.Pharmacoeconomics. 2000 Sep;18(3):225-38. doi: 10.2165/00019053-200018030-00003. Pharmacoeconomics. 2000. PMID: 11147390
-
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.Int Wound J. 2007 Mar;4(1):30-8. doi: 10.1111/j.1742-481X.2006.00274.x. Int Wound J. 2007. PMID: 17425547 Free PMC article.
-
Clinical implications of diabetes on the foot.J Athl Train. 1997 Jan;32(1):55-8. J Athl Train. 1997. PMID: 16558434 Free PMC article.
-
Clinical Profile and Outcome in Patients of Diabetic Foot Infection.Int J Appl Basic Med Res. 2019 Jan-Mar;9(1):14-19. doi: 10.4103/ijabmr.IJABMR_278_18. Int J Appl Basic Med Res. 2019. PMID: 30820414 Free PMC article.